RSS   Newsletter   Contact   Advertise with us
Post Online Media

Clearside Biomedical names chief medical officer

Clearside BiomedicalClearside Biomedical, an ophthalmic company, appoints Richard L. Beckman as chief medical officer.
Article continues below

READ MORE Clearside Biomedical appoints VP, product development

Dr. Beckman is a board certified ophthalmologist who brings 13 years of clinical practice experience and over 20 years of corporate executive and consultancy experience within the global ophthalmic industry to Clearside.

Prior to joining Clearside, Dr. Beckman managed a successful pharmaceutical and medical device industry consulting firm that served a broad range of companies.

Previously, he held the position of Chief Medical Officer and General Manager of the Ocular and Novel Drug Delivery Systems business unit at Unilife Corporation.

Dr. Beckman also held various leadership roles with Ophthotech Pharmaceuticals, Danube Pharmaceuticals, Becton-Dickinson, Neurotech Pharmaceuticals, Alcon Laboratories, Lux Pharmaceuticals and Allergan.

Dr. Beckman received his medical degree from the University of Michigan, and practiced as a glaucoma specialist for ten years in private practice and three years in academic practice at North Shore University Hospital-Cornell University Medical College, following an ophthalmology residency at Henry Ford Hospital and a Glaucoma Fellowship at Harvard University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy